1O'Connor JB, Falk GW, Richter JE. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esop hagus Registry. Am J Gastroenterol, 1999;94:2037
2Geboes K. Barrett's esophagus: the metaplasia-dysplasia-carcinoma sequence:mo rphological aspects. Acta Gastroenterol Belg, 2000;63:13
3Reid BJ, Levine DS, Longton G, et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low-and high-risk patient subsets. Am J Gastroenterol, 2000;95:1669
4Gareth S, Sushovan Guha, Katherine L, et al. Preoperative prevalence of B arrett's esophagus in esophageal adenocarcinoma: A systematic review. Gastroente rology, 2002;122:26
5Douglas A, Theodore R, Laurel A, et al. Surveillance and survival in Barr ett's Adenocarcinoma: A population-based study. Gastroenterology, 2002;122:633
6Morales TG, Sampliner RE, Bhattacharyya T. Intestinal metaplasia of the car dia. Am J Gastroenterol,1997;92:414
7Pereira AD, Suspiro A, Chaves P, et al. Short segments of Barrett's epith elium and intestinal metaplasia in normal appearing oesophagogastric junctions: the same or two different entities?Gut,1998;42:659
8Thomas G, Stephen J, Gregorio A, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology, 2001;120:1 607
9Goldstein NS, Karim R. Gastric cardia inflammation and intestinal metaplasia: associations with reflux esophagitis and helicobacter pylori. Mod Pathol, 1999;1 2:1017
10Couvelard A,Cauvin JM,Goldfain D,et al.Cytokeratin immunoreactivity of i ntestinal metaplasia at normal oesophagogastric junction indicates its aetiology .Gut,2001;49:761
